H J Weinstein
Overview
Explore the profile of H J Weinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1016
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Parsons S, Gelber S, Cole B, Ravindranath Y, Ogden A, Yeager A, et al.
J Clin Oncol
. 1999 Nov;
17(7):2144-52.
PMID: 10561270
Purpose: To describe quality-of-life considerations in post-remission therapies for children with acute myelogenous leukemia. Patients And Methods: A quality-adjusted survival analysis, using the quality-adjusted time without symptoms or toxicity (Q-TWiST)...
12.
Taub J, Huang X, Matherly L, Stout M, Buck S, Massey G, et al.
Blood
. 1999 Aug;
94(4):1393-400.
PMID: 10438727
The high event-free survival rates of Down syndrome (DS) children with acute myeloid leukemia (AML) are due, in part, to increased in vitro sensitivity of DS myeloblasts to cytosine arabinoside...
13.
Catlin E, Roberts Jr J, Erana R, Preffer F, Ferry J, Kelliher A, et al.
N Engl J Med
. 1999 Jul;
341(2):85-91.
PMID: 10395632
No abstract available.
14.
Dranoff G, Weinstein H, Ferrara J, Bierer B, Croop J
Blood
. 1998 Feb;
91(1):222-30.
PMID: 9414288
In an attempt to explore novel treatment modalities in acute myeloid leukemia (AML), we studied the role of costimulatory and cytokine gene immunotherapy in murine AML. We have previously shown...
15.
Ballen K, Gilliland D, Guinan E, Hsieh C, Parsons S, Rimm I, et al.
Bone Marrow Transplant
. 1998 Jan;
20(9):737-43.
PMID: 9384475
Therapy-related myelodysplasia (MDS) is a fatal marrow disorder distinct from primary MDS. We examined the efficacy of bone marrow transplantation (BMT) as a treatment for patients with therapy-related MDS. Eighteen...
16.
Weinstein H, Arceci R, Croop J
J Pediatr Hematol Oncol
. 1998 Jan;
19(6):536-40.
PMID: 9407942
Purpose: Characterization of B7.1 and GM-CSF vaccines on the induction of anti-tumor immunity in a murine AML model. Materials And Methods: Primary AML cells were retrovirally transduced with the murine...
17.
Mehta N, Reed C, Kuhlman C, Weinstein H, Parsons S
Oncol Nurs Forum
. 1997 Dec;
24(9):1539-44.
PMID: 9348595
Purpose/objectives: To compare the efficacy of two antiemetic regimens, ondansetron alone versus perphenazine with diphenhydramine, on emesis control in children undergoing conditioning therapy for bone marrow transplantation (BMT). Design: Single-center,...
18.
Laver J, Shearer P, Krance R, Hurwitz C, Srivastava D, Weinstein H, et al.
Leuk Lymphoma
. 1997 Aug;
26(5-6):589-93.
PMID: 9389365
Relapse in acute myeloid leukemia (AML) following intensive chemotherapy bears a bad prognosis. We treated 18 children with relapsed AML on two separate protocols that included continuous infusion (CI) of...
19.
Ebb D, Weinstein H
Pediatr Clin North Am
. 1997 Aug;
44(4):847-62.
PMID: 9286288
Acute myelogenous leukemia (AML) accounts for about 20% of the acute leukemias seen in children. In contrast to childhood acute lymphoblastic leukemia (ALL), there has only been a modest improvement...
20.
Chan C, Molrine D, Antin J, Wheeler C, Guinan E, Weinstein H, et al.
Bone Marrow Transplant
. 1997 Jul;
20(1):33-8.
PMID: 9232253
Accelerated granulocyte and platelet recovery following peripheral blood stem cell transplantation (PBSCT) are well documented. We hypothesize that functional immunity may also be enhanced in PBSCT and performed a phase...